首页> 外国专利> Modified Gram negative bacteria for use as vaccine and adjuvant - are transformed to express lytic protein or toxin, forming ghost(s) which present many cell wall epitope(s)

Modified Gram negative bacteria for use as vaccine and adjuvant - are transformed to express lytic protein or toxin, forming ghost(s) which present many cell wall epitope(s)

机译:用作疫苗和佐剂的修饰革兰氏阴性细菌被转化以表达裂解蛋白或毒素,形成具有许多细胞壁表位的幽灵

摘要

Modified bacteria, obtd. by (1) transforming a Gram negative bacterium with (a) the gene of a lytic membrane protein of a bacteriophage, (b) a lytic toxin-release gene or (c) their partial sequences which code for lytic proteins; (2) culturing the bacteria, (3) expressing the lytic genes and (4) isolation from the culture broth, are used as vaccines or adjuvants. - Pref. during culture, activation of the gene is inhibited or expression is repressed, and lifted only at selected times. The lytic gene is the DNA sequence for the E or L proteins (or their membrane-penetrating domains) or the EL-hybrid protein, or their active partial sequences.
机译:改良细菌,无味。通过(1)用(a)噬菌体裂解膜蛋白的基因,(b)裂解毒素释放基因或(c)其编码裂解蛋白的部分序列,转化革兰氏阴性细菌; (2)培养细菌,(3)表达裂解基因,(4)从培养液中分离,用​​作疫苗或佐剂。 -好在培养期间,仅在选定的时间抑制基因的激活或抑制表达,并解除表达。裂解基因是E或L蛋白(或其膜穿透域)或EL杂合蛋白的DNA序列,或它们的活性部分序列。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号